Abstract

An efficient and green method for synthesis of 2,4,5-triarylimidazoles without use of any catalyst or solvent has been developed simply by heating (at 130°C) of mixtures of 1,2-diketone, aromatic aldehyde, and ammonium acetate in 1 : 1 : 3 mole ratio.

1. Introduction

Multicomponent reactions (MCRs) have emerged as a powerful tool for convergent synthesis of many complex organic molecules [16]. They are one-pot processes bringing together three or more components in a particular sequence of reactions and show high atom economy and remarkable selectivity. Because of their operational simplicity, MCRs have occupied a very prominent place in diversity oriented synthesis which is an important requirement for drug discovery. The imidazole nucleus is a rich source for getting biologically important organic molecules. Compounds containing imidazole moiety show a range of pharmacological properties and play important roles in biochemical processes. Various substituted imidazoles act as inhibitors of P38 MAP kinase [7] and B-Raf kinase [8], glucagon receptors [9], pesticides [10], fungicides [10], herbicides [11], and antitumor [12], anti-inflammatory [13], and antithrombotic [14] agents. Moreover, they are used in photography as photosensitive compounds [15]. 2,4,5-Triarylimidazoles (3) form an important group of substituted imidazoles having many of the above biological activities and material properties. Retrosynthetic analysis of 3 suggests the readily available compounds aromatic 1,2-diketones, aromatic aldehydes, and ammonia as their precursors. This has led to the development of a large number of synthetic methods for 3 using these simple starting materials. Almost all of these methods use ammonium acetate as the ammonia source. Many of the reported methods require long reaction time and use of expensive catalysts and organic solvents [1623]. The current literature shows that there has been a growing trend towards green synthesis of these compounds [24, 25]. However, in such reported green methods, also use of catalysts or organic solvents could not be avoided. The current trend towards development of catalyst-free and solvent-free reaction conditions for organic synthesis [26, 27] encouraged us to study the same reaction under thermal condition without using any solvent or catalyst. The remarkable success in this endeavor is presented herein.

2. Results and Discussion

Our present method involves subjecting of an intimate mixture of 1,2-diketone, aromatic aldehyde, and ammonium acetate in 1 : 1 : 3 mole ratio directly to heat (130°C, 3–6 h). A range of structurally diverse aldehydes belonging to the categories aromatic and heterocyclic aldehydes were taken (Scheme 1). To our delight, the target compounds were obtained in good to very good yield in this method for all the combinations. The yields of the products are presented in Table 1.

512074.sch.001

In the method being reported, it was a common observation that the reactions were very clean and no side product was formed in any run. In fact, the crude products obtained were of high purity and did not require any chromatographic separation. Their crystallization from ethanol provided analytically pure samples. More significantly, the whole operation did not require any solvent, organic or inorganic, at any stage. Furthermore, the reaction condition has been found to be mild enough to tolerate a variety of functionalities such as NO2, Cl, OH, and OMe.

3. Conclusion

We report here a very simple and efficient green method for synthesis of 2,4,5-triarylimidazoles avoiding the use of any solvent, catalyst, and solid surface.

4. Experimental

4.1. General

Melting points were recorded on a Köfler block. IR spectra were recorded on a Perkin Elmer FT-IR spectrophotometer (Spectrum BX II) in KBr pellets. 1H NMR spectra and 13C NMR spectra were recorded in CDCl3 on a Bruker AV-300 (300 MHz) spectrometer. Analytical samples were routinely dried in vacuo at room temperature. Microanalytical data were recorded on two Perkin-Elmer 2400 Series II C, H, N analyzers. Mass spectra were measured in the following ways FAB-MS [Jeol the M Station JMS.700]. TLC was performed with silica gel G made by SRL Pvt. Ltd. Petroleum ether had the boiling range 60–80°C.

4.2. General Method for Synthesis of 2,4,5-Triarylimidazoles (3)

In a typical experiment, an intimate mixture of benzil (1 mmol), aromatic aldehyde (1 mmol), and ammonium acetate (3 mmol) was taken in a round-bottom flask (50 mL) fitted with a CaCl2-guard tube and the flask was heated in an oil bath at 130°C. Initially, the reaction mixture melted and after some time (ca. 1–3 h) it began to solidify. When the reaction mixture solidified totally (time period mentioned in Table 1), it was cooled to room temperature and to it water (20 mL) was added. The resulting solid mass was crushed and it was filtered, and the residue was washed with water and then dried. The crude product so obtained was crystallized from ethanol.

All of the products 3a-n were known compounds and were identified by comparison of their physical and spectral data with those reported in the literature. The spectral data recorded by us are given below.

4.2.1. Compound 3a

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): and 7.95 (br. d, 2H, J = 8.1 Hz), 7.59 (br. d, 4H, J = 7.8 Hz), 7.28–7.48 (m, 9H); Anal. Calcd. for C21H16N2 (296.37): C, 85.11; H, 5.44; N, 9.45. Found: C, 85.26; H, 5.72; N, 9.31.

4.2.2. Compound 3b

Colorless needles, IR (KBr, cm−1): 3414, 3027, 2363, 1654, 1601, 1493, 1449, 1381; 1H NMR (300 MHz, CDCl3, δ/ppm): 7.86 (d, 2H, J = 8.1 Hz), 7.50 (br. d, 4H, J   7.8 Hz), 7.21–7.31 (m, 8H), 2.38 (s, 3H, CH3); 13C NMR (75 MHz, CDCl3, δ/ppm): 146.2, 138.9, 132.9, 129.6, 128.6, 127.8, 127.4, 127.1, 125.2, 21.3; FAB MS (M + H)+: Calcd. 311.3. Found 311.3; Anal. Calcd. for C22H18N2 (310.39): C, 85.13; H, 5.85; N, 9.03. Found: C, 84.86; H, 5.75; N, 8.82.

4.2.3. Compound 3c

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 7.83 (d, 2H, J = 8.7 Hz), 7.53 (br. d, 4H, J   7.0 Hz), 7.28−7.40 (m, 8H).

4.2.4. Compound 3d

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 7.78 (d, 2H, J = 8.5 Hz), 7.54–7.58 (m, 6H), 7.28–7.38 (m, 6H).

4.2.5. Compound 3e

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 7.88 (br. d, 2H, J = 8.4 Hz), 7.49 (br. d, 4H, J   6.6 Hz), 7.24–7.30 (m, 6H), 6.93 (d, 2H, J = 9 Hz), 3.82 (s, 3H).

4.2.6. Compound 3f

Colorless needles, 1H NMR (300 MHz, d6-DMSO, δ/ppm): 12.49 (s, 1H, NH), 7.21–7.63 (m, 12H), 7.03 (d, 1H, J = 8.4), 6.08 (s, 2H, –OCH2O–); 1H NMR (300 MHz, CDCl3, δ/ppm): 7.52 (br. d, 4H, J   7.2 Hz), 7.39 (d, 1H, J = 8.2 Hz), 7.46 (br. s, 1H), 7.26–7.33 (m, 5H), 6.83 (d, 1H, J = 8.0 Hz), 6.00 (s, 2H, –OCH2O–).

4.2.7. Compound 3g

Yellow needles, 1H NMR (300 MHz, d6-DMSO, δ/ppm): 13.08 (s, 1H), 8.94 (s, 1H), 8.50 (d, 1H, J = 7.8 Hz), 8.19 (d, 1H, J = 8.1 Hz), 7.76 (t, 1H, J = 7.8 Hz), 7.32–7.53 (m, 10H).

4.2.8. Compound 3h

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 7.82 (d, 2H, J = 7.7 Hz), 7.52–7.54 (m, 4H), 7.26–7.33 (m, 6H), 6.74 (d, 2H, J = 7.8 Hz), 2.99 (s, 6H, NMe2).

4.2.9. Compound 3i

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 12.40 (br. s, 1H, NH), 9.24 (br. s, 1H, OH), 7.19–7.54 (m, 11H), 7.61 (br. s, 1H), 6.84 (d, 1H, J = 8.2 Hz), 3.84 (s, 3H, OCH3).

4.2.10. Compound 3j

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 7.70 (br. d, 1H, J   3 Hz), 7.43–7.46 (m, 4H), 7.31 (dd, 1H, J = 5.1 and 1.0 Hz), 7.24−7.28 (m, 6H), 7.04 (dd, 1H, J = 4.8 and 3.7 Hz).

4.2.11. Compound 3k

Colorless needles, IR (KBr, cm−1): 3376, 3052, 2200, 1663, 1604, 1563, 1469, 1438, 1382; 1H NMR (300 MHz, CDCl3, δ/ppm): 9.28 (br. s, 1H, H-2 of 3-pyridyl), 8.50 (d, 1H, J = 8.0 Hz, H-4 of 3-pyridyl), 8.43 (d, 1H, J = 4.6 Hz, H-6 of 3-pyridyl), 7.54–7.56 (m, 4H, o-proton of 2 × C6H5), 7.28–7.39 (m, 7H, m- and p-protons of 2 × C6H5 and H-5 of 3-pyridyl); 13C NMR (75 MHz, CDCl3, δ/ppm) 148.9, 145.9, 143.1, 133.5, 132.6, 128.6, 128.0, 127.6, 126.7, 123.9; FAB MS (M + H)+: Calcd. 298.3. Found 298.3, Anal. Calcd. for C20H15N3 (297.35): C, 80.78; H, 5.08; N, 14.13. Found: C, 80.56; H, 5.31; N, 13.92.

4.2.12. Compound 3l

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 7.90 (d, 2H, J = 7.8 Hz), 7.42–7.48 (m, 6H), 7.36 (t, 1H, J = 7.5), 7.16 (d, 4H, J = 7.8 Hz), 2.36 (s, 6H, 2 × –CH3).

4.2.13. Compound 3m

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 7.83 (2H, d, J = 8.1 Hz), 7.43 (d, 4H, J = 7.8 Hz), 7.40 (2H, d, J = 8.1 Hz), 7.14 (d, 4H, J = 7.6 Hz), 2.36 (s, 6H, 2 × –CH3).

4.2.14. Compound 3n

Colorless needles, 1H NMR (300 MHz, CDCl3, δ/ppm): 7.83 (d, 2H, J = 8.4 Hz), 7.43 (br. d, 4H, J = 7.2 Hz), 7.13 (br. d, 4H, J = 7.6 Hz), 6.96 (d, 2H, J = 8.5 Hz), 3.85 (s, 3H, –OCH3), 2.36 (s, 6H, 2 × –CH3).

Acknowledgments

Financial assistance from the UGC-CAS and DST-PURSE programs, Department of Chemistry, is gratefully acknowledged. The authors also acknowledge the DST-FIST program of the Department of Chemistry, Jadavpur University, for providing the NMR spectral data. S. Samanta is thankful to the CSIR and S. Sarkar to the UGC, New Delhi, for their research fellowships.

Supplementary Materials

Scheme 1: 1H NMR Spectrum of Compound 3a (CDCl3).

Scheme 2: 1H NMR Spectrum of Compound 3b (CDCl3).

Scheme 3: 13 NMR Spectrum of Compound 3b (CDCl3).

Scheme 4: IR Spectrum of Compound 3b.

Scheme 5: MASS Spectrum of Compound 3b.

Scheme 6: 1H NMR Spectrum of Compound 3c (CDCl3).

Scheme 7: 1H NMR Spectrum of Compound 3d (CDCl3).

Scheme 8: 1H NMR Spectrum of Compound 3e (CDCl3).

Scheme 9: 1H NMR Spectrum of Compound 3f (CDCl3).

Scheme 10: 1H NMR Spectrum of Compound 3f (DMSO-d6).

Scheme 11: 1H NMR Spectrum of Compound 3g (DMSO-d6).

Scheme 12: 1H NMR Spectrum of Compound 3i (DMSO-d6).

Scheme 13: 1H NMR Spectrum of Compound 3h (CDCl3).

Scheme 14: 1H NMR Spectrum of Compound 3j (CDCl3).

Scheme 15: 1H NMR Spectrum of Compound 3k (CDCl3).

Scheme 16: 13C NMR Spectrum of Compound 3k (CDCl3).

Scheme 17: IR Spectrum of Compound 3k.

Scheme 18: MASS Spectrum of Compound [-3Pyridyl].

Scheme 19: 1H NMR Spectrum of Compound 3l (CDCl3).

Scheme 20: 1H NMR Spectrum of Compound 3m (CDCl3).

Scheme 20: 1H NMR Spectrum of Compound 3m (CDCl3).

  1. Supplementary Material